Синдром низкой передней резекции после операций по поводу рака прямой кишки низкой локализации: обзор литературы
pdf

Ключевые слова

рак прямой кишки;
синдром низкой передней резекции
тотальная мезоректумэктомия
недержание кала

Как цитировать

Захаренко, А. А., Гайнуллина, Л. И., Свечкова, А. А., Тен, О. А., & Хамид, А. Х. (2024). Синдром низкой передней резекции после операций по поводу рака прямой кишки низкой локализации: обзор литературы. Вопросы онкологии, 70(2), 224–232. https://doi.org/10.37469/0507-3758-2024-70-2-224-232

Аннотация

Колоректальный рак по своей распространенности занимает одну из лидирующих позиций в структуре онкологических заболеваний, при этом на долю рака прямой кишки приходится более трети всех случаев. Оперативное лечение, включающее этап тотальной мезоректумэктомии, в комбинации с неоадъювантной лучевой терапией является стандартом лечения средне- и нижнеампулярного рака прямой кишки.  По данным литературы, до 90 % пациентов, перенесших переднюю резекцию прямой кишки, сообщают о различных проявлениях дисфункции кишечника в послеоперационном периоде, объединенных в синдром низкой передней резекции. Выраженность функциональных расстройств при данном синдроме варьируется по степени тяжести и оценивается по шкале LARS, при этом тяжесть синдрома коррелирует со снижением качества жизни пациентов. Основными этиологическими факторами развития являются нарушение иннервации сфинктера и механическое его повреждение. Лечение синдрома низкой передней резекции принято разделять на 3 линии — от консервативной терапии и терапии биологической обратной связи до стимуляции крестцового нерва, и выведении постоянной колостомы при рефрактерности к лечению в течении двух лет и более.

https://doi.org/10.37469/0507-3758-2024-70-2-224-232
Загрузок: 141
Просмотров: 386
pdf

Библиографические ссылки

Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209-249.-DOI: https://doi.org/10.3322/caac.21660.

Hong Y., Kim J., Choi Y.J., et al. Clinical study of colorectal cancer operation: Survival analysis. Korean J Clin Oncol. 2020; 16(1): 3-8.-DOI: https://doi.org/10.14216/kjco.20002.

Федянин М.Ю., Гладков О.А., Гордеев С.С., и др. Практические рекомендации по лекарственному лечению рака ободочной кишки, ректосигмоидного соединения и прямой кишки. Злокачественные опухоли: Практические рекомендации RUSSCO. 2022; 12(3s2-1): 401-54.-DOI: https://doi.org/10.18027/2224-5057-2022-12-3s2-401-454.

[Fedyanin M.Yu., Gladkov O.A., Gordeev S.S., et al. M.V. practical recommendations for the drug treatment of colon cancer, rectosigmoid junction and rectum. Malignant Tumors: Practical recommendations RUSSCO. 2022; 12(3s2-1): 401-54.-DOI: https://doi.org/10.18027/2224-5057-2022-12-3s2-401-454. (In Rus)].

Tsukamoto S., Kanemitsu Y., Shida D., et al. Comparison of the clinical results of abdominoperanal intersphincteric resection and abdominoperineal resection for lower rectal cancer. Int J Colorectal Dis. 2017; 32(5): 683-9.-DOI: https://doi.org/10.1007/s00384-017-2755-2.

Hughes D.L., Cornish J., Morris C., et al. Functional outcome following rectal surgery—predisposing factors for low anterior resection syndrome. Int J Colorectal Dis. 2017; 32(5): 691-7.-DOI: https://doi.org/10.1007/s00384-017-2765-0.

Nguyen T.H., Chokshi R.V. Low anterior resection syndrome. Curr Gastroenterol Rep. 2020; 22(10).-DOI: https://doi.org/10.1007/s11894-020-00785-z.

Enli S., Çolak T., Türkmenoğlu M.Ö. Factors influencing anterior/low anterior resection syndrome after rectal or sigmoid resections. Turk J Med Sci. 2021; 51(2): 623-30.-DOI: http://dx.doi.org/10.3906/sag-2007-145.

Miacci F.L.C., Guetter C.R., Moreira P.H., et al. Síndrome da ressecção anterior do reto: fatores preditivos. Rev Col Bras Cir. 2019; 46(6).-DOI: https://doi.org/10.1590/0100-6991e-20192361.

Kupsch J., Jackisch T., Matzel K.E., et al. Outcome of bowel function following anterior resection for rectal cancer—an analysis using the low anterior resection syndrome (LARS) score. Int J Colorectal Dis. 2018; 33(6): 787-98.-DOI: https://doi.org/10.1007/s00384-018-3006-x.

Sun W., Dou R., Chen J., et al. Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and quality of life in rectal cancer: post hoc analysis of a randomized controlled trial. Ann Surg Oncol. 2018; 26(3): 746-55.-DOI: https://doi.org/10.1245/s10434-018-07096-8.

Marti W.R., Curti G., Wehrli, et al. Clinical outcome after rectal replacement with side-to-end, colon-j-pouch, or straight colorectal anastomosis following total mesorectal excision. Ann Surg. 2019; 269(5): 827-35.-DOI: https://doi.org/10.1097/sla.0000000000003057.

Sun R., Dai Z., Zhang Y., et al. The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis. Support Care Cancer. 2021; 29(12): 7249-58.-DOI: https://doi.org/10.1007/s00520-021-06326-2.

Расулов А.О., Байчоров А.Б., Мерзлякова А.М., и др. Реконструкция прямой кишки после тотальной мезоректумэктомии: функциональные результаты и качество жизни. Креативная хирургия и онкология. 2021; 11(3): 195-202.-DOI: https://doi.org/10.24060/2076-3093-2021-11-3-195-202.

[Rasulov A.O., Baichorov A.B., Merzlyakova A.M., et al. Reconstruction of the rectum after total mesorectal excision: functional results and quality of life. Creative Surgery and Oncology. 2021; 11(3): 195-202.-DOI: https://doi.org/10.24060/2076-3093-2021-11-3-195-202. (In Rus)].

Kim S., Kang S.I., Kim S.H., et al. The effect of anastomotic leakage on the incidence and severity of low anterior resection syndrome in patients undergoing proctectomy: a propensity score matching analysis. Ann Coloproctol. 2021; 37(5): 281-90.-DOI: https://doi.org/10.3393/ac.2021.03.15.

Jutesten H., Buchwald P.L., Angenete E., et al. High risk of low anterior resection syndrome in long-term follow-up after anastomotic leakage in anterior resection for rectal cancer. Dis Colon Rectum. 2021; 65(10): 1264-73.-DOI: https://doi.org/10.1097/dcr.0000000000002334.

Annicchiarico A., Martellucci J., Solari S., et al. Low anterior resection syndrome: can it be prevented? Int J Colorectal Dis. 2021; 36(12): 2535-52.-DOI: https://doi.org/10.1007/s00384-021-04008-3.

Garg P.K., Goel A., Sharma S., et al. Protective diversion stoma in low anterior resection for rectal cancer: a meta-analysis of randomized controlled trials. Visc Med. 2019; 35(3): 156-60.-DOI: https://doi.org/10.1159/000497168.

Sandberg S., Asplund D., Bisgaard T., et al. Low anterior resection syndrome in a Scandinavian population of patients with rectal cancer: a longitudinal follow‐up within the QoLiRECT study. Colorectal Dis. 2020; 22(10): 1367-78.-DOI: https://doi.org/10.1111/codi.15095.

Sturiale A., Martellucci J., Zurli L., et al. Long-term functional follow-up after anterior rectal resection for cancer. Int J Colorectal Dis. 2016; 32(1): 83-8.-DOI: https://doi.org/10.1007/s00384-016-2659-6.

Jiménez-Rodríguez R.M., Segura-Sampedro J.J., Rivero-Belenchón I., et al. Is the interval from surgery to ileostomy closure a risk factor for low anterior resection syndrome? Colorectal Dis. 2017; 19(5): 485-90.-DOI: https://doi.org/10.1111/codi.13524.

Sylla P., Rattner D.W., Delgado S., et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010; 24(5): 1205-10.-DOI: https://doi.org/10.1007/s00464-010-0965-6.

Alimova I., Chernyshov S., Nagudov M., et al. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021; 25(8): 901-13.-DOI: https://doi.org/10.1007/s10151-021-02420-z.

Bregendahl S., Emmertsen K.J., Lous J., et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 2013; 15(9): 1130–9.-DOI: https://doi.org/10.1111/codi.12244.

Liang Z., Zhang Z., Wu D., et al. Effects of preoperative radiotherapy on long-term bowel function in patients with rectal cancer treated with anterior resection: a systematic review and meta-analysis. Technol Cancer Res Treat. 2022; 21: 153303382211051.-DOI: https://doi.org/10.1177/15330338221105156.

Ye L., Huang M., Huang Y., et al. Risk factors of postoperative low anterior resection syndrome for colorectal cancer: A meta-analysis. Asian J Surg. 2022; 45(1): 39-50.-DOI: https://doi.org/10.1016/j.asjsur.2021.05.016.

Sun W., Dou R., Chen J., et al. Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and quality of life in rectal cancer: post hoc analysis of a randomized controlled trial. Ann Surg Oncol. 2018; 26(3): 746-55.-DOI: https://doi.org/10.1245/s10434-018-07096-8.

Zhang Q., An L., Yu R., et al. The impact of neoadjuvant chemotherapy on low anterior resection syndrome after rectal cancer resection: A 6 Months longitudinal follow-up. Asian J Surg. 22021; 44(10): 1260-5.-DOI: https://doi.org/10.1016/j.asjsur.2021.02.010.

Dulskas A., Kavaliauskas P., Kulikauskas E., et al. Low anterior resection syndrome: what have we learned assessing a large population? J Clin Med. 2022; 11(16): 4752.-DOI: https://doi.org/10.3390/jcm11164752.

Koda K., Yamazaki M., Shuto K., et al. Etiology and management of low anterior resection syndrome based on the normal defecation mechanism. Surg Today. 2019; 49(10): 803-8.-DOI: https://doi.org/10.1007/s00595-019-01795-9.

Ishiyama G., Hinata N., Kinugasa Y., et al. Nerves supplying the internal anal sphincter: an immunohistochemical study using donated elderly cadavers. Surg Radiol Anat. 2014; 36(10): 1033-42.-DOI: https://doi.org/10.1007/s00276-014-1289-3.

Emmertsen K.J., Laurberg S. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013; 100(10): 1377-87.-DOI: https://doi.org/10.1002/bjs.9223.

Foo C.C., Kin Ng K., Tsang J.S., et al. Low anterior resection syndrome after transanal total mesorectal excision: a comparison with the conventional top-to-bottom approach. Dis Colon Rectum. 2020; 63(4): 497-503.-DOI: https://doi.org/10.1097/dcr.0000000000001579.

Chen T.Y., Wiltink L.M., Nout R.A., et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomized trial. Clin Colorectal Cancer. 2015; 14(2): 106-14.-DOI: http://dx.doi.org/10.1016/j.clcc.2014.12.007.

Jorge M.J.N., Wexner S.D. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993; 36(1): 77-97.-DOI: https://doi.org/10.1007/bf02050307.

Emmertsen K.J., Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012; 255(5): 922-8.-DOI: https://doi.org/10.1097/sla.0b013e31824f1c21.

Pieniowski E.H.A., Palmer G.J., Juul T., et al. Low anterior resection syndrome and quality of life after sphincter-sparing rectal cancer surgery: a long-term longitudinal follow-up. Dis Colon Rectum. 2019; 62(1): 14-20.-DOI: https://doi.org/10.1097/dcr.0000000000001228.

Temple L.K., Bacik J., Savatta S.G., et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005; 48(7): 1353-65.-DOI: https://doi.org/10.1007/s10350-004-0942-z.

Quezada-Diaz F.F., Elfeki H., Emmertsen K.J., et al. Comparative analysis of the Memorial Sloan Kettering Bowel Function Instrument and the Low Anterior Resection Syndrome Questionnaire for assessment of bowel dysfunction in rectal cancer patients after low anterior resection. Colorectal Dis. 2021; 23(2): 451-60.-DOI: https://doi.org/10.1111/codi.15515.

Cura Pales C.G., An S., Cruz J.P., et al. Postoperative bowel function after anal sphincter-preserving rectal cancer surgery: risks factors, diagnostic modalities, and management. Ann Coloproctol. 2019; 35(4): 160-6.-DOI: https://doi.org/10.3393/ac.2019.08.10.

Ihnát P., Vávra P., Prokop J., et al. Functional outcome of low rectal resection evaluated by anorectal manometry. ANZ J Surg. 2017; 88(6).-DOI: https://doi.org/10.1111/ans.14207.

Kakodkar R., Gupta S., Nundy S. Low anterior resection with total mesorectal excision for rectal cancer: functional assessment and factors affecting outcome. Colorectal Dis. 2006; 8(8): 650-6.-DOI: https://doi.org/10.1111/j.1463-1318.2006.00992.x.

Rosen H.R., Kneist W., Fürst A., et al. Randomized clinical trial of prophylactic transanal irrigation versus supportive therapy to prevent symptoms of low anterior resection syndrome after rectal resection. BJS Open. 2019; 3(4): 461-5.-DOI: https://doi.org/10.1002/bjs5.50160.

Martellucci J. Low anterior resection syndrome: A treatment algorithm. Dis Colon Rectum. 2016; 59(1): 79-82.-DOI: https://doi.org/10.1097/dcr.0000000000000495.

Kauff D.W., Roth Y.D.S., Bettzieche R.S., et al. Fecal incontinence after total mesorectal excision for rectal cancer—impact of potential risk factors and pelvic intraoperative neuromonitoring. World J Surg Oncol. 2020; 18(1).-DOI: https://doi.org/10.1186/s12957-020-1782-6.

Bliss D.Z., Savik K., Jung H.J., et al. Dietary fiber supplementation for fecal incontinence: A randomized clinical trial. Res Nurs Health. 2014; 37(5): 367-78.-DOI: https://doi.org/10.1002/nur.21616.

Paquette I.M., Varma M.G., Kaiser A.M., et al. The American Society of Colon and Rectal Surgeons’ clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015; 58(7): 623-36.-DOI: https://doi.org/10.1097/dcr.0000000000000397.

Ryoo S.B., Park J.W., Lee D.W., et al. Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer. Br J Surg. 2021; 108(6): 644-51.-DOI: https://doi.org/10.1093/bjs/znab071.

McCutchan G.M., Hughes D., Davies Z., et al. Acceptability and benefit of rectal irrigation in patients with low anterior resection syndrome: a qualitative study. Colorectal Dis. 2018; 20(3).-DOI: https://doi.org/10.1111/codi.13985.

Pieniowski E.H.A., Bergström C.M., Nordenvall C.A.M., et al. A randomized controlled clinical trial of transanal irrigation versus conservative treatment in patients with low anterior resection syndrome after rectal cancer surgery. Ann Surg. 2022; 277(1): 30-7.-DOI: https://doi.org/10.1097/sla.0000000000005482.

Rodrigues B.D.S., Rodrigues F.P., Buzatti K., et al. Feasibility study of transanal irrigation using a colostomy irrigation system in patients with low anterior resection syndrome. Dis Colon Rectum. 2022; 65(3): 413-20.-DOI: https://doi.org/10.1097/dcr.0000000000002005.

Tazhikova A., Makishev A., Bekisheva A., et al. Efficacy of tibial nerve stimulation on fecal incontinence in patients with low anterior resection syndrome following surgery for colorectal cancer. Ann Rehabil Med. 2022; 46(3): 142-53.-DOI: https://doi.org/10.5535/arm.22025.

Marinello F.G., Jiménez L.M., Talavera E., et al. Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial. Br J Surg. 2021; 108(4): 380-7.-DOI: https://doi.org/10.1093/bjs/znaa171.

Enriquez-Navascues J.M., Labaka-Arteaga I., Aguirre-Allende I., et al. A randomized trial comparing transanal irrigation and percutaneous tibial nerve stimulation in the management of low anterior resection syndrome. Colorectal Disease. 2019; 22(3): 303-9.-DOI: https://doi.org/10.1111/codi.14870.

Asnong A., D'Hoore A., Van Kampen M., et al. The role of pelvic floor muscle training on low anterior resection syndrome. Ann Surg. 2022; 276(5): 761-8.-DOI: https://doi.org/10.1097/sla.0000000000005632.

Lee K.H., Kim J.S., Kim J.Y. Efficacy of biofeedback therapy for objective improvement of pelvic function in low anterior resection syndrome. Ann Surg Treat Res. 2019; 97(4): 194.-DOI: https://doi.org/10.4174/astr.2019.97.4.194.

Wu X.D., Fu C.F., Chen Y.L., et al. Intervention effect of biofeedback combined with pelvic floor muscle exercise on low anterior resection syndrome in patients with low anus-preserving rectal cancer (Chin). Zhonghua Yi Xue Za Zhi. 2019; 99(30): 2337-43.-DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2019.30.004.

Martellucci J. Low anterior resection syndrome. Dis Colon Rectum. 2016; 59(1): 79-82.-DOI: https://doi.org/10.1097/dcr.0000000000000495.

Mege D., Meurette G., Vitton V., et al. Sacral nerve stimulation can alleviate symptoms of bowel dysfunction after colorectal resections. Colorectal Dis. 2017; 19(8): 756-63.-DOI: https://doi.org/10.1111/codi.13624.

Croese A.D. et al. Using sacral nerve modulation to improve continence and quality of life in patients suffering from low anterior resection syndrome. ANZ J Surg. 2018; 88(11): E787–E791.-DOI: https://doi.org/10.1111/ans.14871.

Croese A.D., Whiting S., Vangaveti, V.N., et al. The efficacy of sacral neuromodulation in the treatment of low anterior resection syndrome: a systematic review and meta-analysis. Tech Coloproctol. 2020; 24(8): 803-15.-DOI: https://doi.org/10.1007/s10151-020-02231-8.

De Meyere C., Nuytens F., Parmentier I., et al. Five-year single center experience of sacral neuromodulation for isolated fecal incontinence or fecal incontinence combined with low anterior resection syndrome. Tech Coloproctol. 2020; 24(9): 947-58.-DOI: https://doi.org/10.1007/s10151-020-02245-2.

Rubio-Perez I., Saavedra J., Marijuan J.L., et al. Optimizing sacral neuromodulation for low anterior resection syndrome: learning from our experience. Colorectal Dis. 2020; 22(12): 2146-54.-DOI: https://doi.org/10.1111/codi.15261.

Sarcher T., Dupont B., Alves A., et al. Anterior resection syndrome: What should we tell practitioners and patients in 2018? J Visc Surg. 2018; 155(5): 383-91.-DOI: https://doi.org/10.1016/j.jviscsurg.2018.03.006.

Dinnewitzer A., Jäger T., Nawara C., et al. Cumulative incidence of permanent stoma after sphincter preserving low anterior resection of mid and low rectal cancer. Dis Colon Rectum. 2013; 56(10): 1134-42.-DOI: https://doi.org/10.1097/dcr.0b013e31829ef472.

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

© АННМО «Вопросы онкологии», Copyright (c) 2024